17:33 EDT Precigen (PGEN) files to sell 143.81M shares of common stock for holders
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGEN:
- Buy Rating for Precigen: Strong Market Potential and Strategic Positioning of Papzimeos
- Precigen price target raised to $8 from $6 at Citizens JMP
- Precigen Enters Commercial Supply Agreement with Catalent
- Unusually active option classes on open August 18th
- Precigen’s PAPZIMEOS Receives FDA Approval for RRP